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DETECTION OF PLASMODIUM FALCIPARUM IN PREGNANCY BY LASER
DESORPTION MASS SPECTROMETRY
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PLAMEN A. DEMIREV, JEFFREY S. LIN, LIRONG SHI, NIRBHAY KUMAR, AND DAVID J. SULLIVAN, JR.*
Division of Clinical Pharmacology, The Johns Hopkins University School of Medicine, Baltimore, Maryland; W. Harry Feinstone
Department of Molecular Microbiology and Immunology, Department of Environmental Health Sciences, Johns Hopkins University
Bloomberg School of Public Health, Baltimore, Maryland; Malaria Institute at Macha, Choma, Zambia; M. S. Eisenhower Research
and Technology Development Center, Johns Hopkins University Applied Physics Laboratory, Laurel, Maryland
Abstract. Detection of Plasmodium falciparum malaria during pregnancy is complicated by sequestration of para-
sites in the placenta, which reduces peripheral blood microscopic detection. Laser desorption mass spectrometry
(LDMS) has previously demonstrated sensitive detection of hemozoin from P. falciparum blood cultures and the ability
to track parasitemia in a Plasmodium yoelii malaria mouse model. Here we use a simple, dilution in water, blood sample
preparation protocol for LDMS detection of malaria in 45 asymptomatic, pregnant Zambian women. We compare
LDMS to microscopy and polymerase chain reaction (PCR) analysis. All women were microscopy negative. LDMS
detected P. falciparum hemozoin in 15 out of 45 women, while PCR results were positive in 25 women. Compared with
PCR, which analyzed 20–30 L of blood, the sensitivity of LDMS, which analyzed < 1 L of blood, was 52%, with a
specificity of 92%. LDMS is a potentially rapid and more sensitive alternate diagnostic method than microscopy.
INTRODUCTION
Worldwide, 50 million pregnant women are exposed to ma-
laria infection annually. In Africa, 42% of women have ma-
laria at some point during their pregnancy.1 Although fre-
quently asymptomatic in hyperendemic areas, malaria infec-
tion during pregnancy is associated with maternal anemia,
premature delivery, intrauterine growth retardation, and low
birth weight, which is the greatest indicator of neonatal mor-
tality.2 These complications are associated with the infected
erythrocyte sequestration in the placenta, which is thought to
interfere with placental nutrient transfer.3 Management of
malaria in pregnancy is increasingly difficult due to a number
of factors, among them the rapid rise of chloroquine-resistant
Plasmodium falciparum in the past decade, a severely limited
choice of alternative safe drugs, and limitations in diagno-
sis.4–6
Optical microscopic examination of peripheral-blood
smears for parasitemia during pregnancy is known to miss a
significant portion of placental infections.7 Theoretically,
thick film microscopy can detect approximately 50–100 para-
sites per microliter, while a practical working number is often
500–1,000 per microliter.8 Immunochromatographic assays,
based on detection of histidine-rich protein II (HRP II) or
glycolytic enzymes, are designed with a working threshold of
approximately 100 parasites per microliter.9 PCR, a research
“gold standard,” has been estimated to detect as little as 5
parasites or less per microliter.8 Many of these sensitivities
will vary based on total volume of blood processed for analy-
sis. A large study conducted in Cameroon showed that more
than 20% of placental infections were missed by microscopic
examination of peripheral blood and that the detection was
improved to about 90% by additional use of the immunochro-
matographic test for HRP 2.7
The biomarker for detecting malaria infection by laser de-
sorption mass spectrometry (LDMS) is heme from hemozoin.
An intraerythrocytic Plasmodium parasite digests up to ∼0.4
femtomoles of hemoglobin, crystallizing the released toxic
heme into hemozoin in the acidic, oxygen-rich food vacuole.10
While trophozoites are named for the presence of heme crys-
tals visible by light microscopy, ring-stage parasites also con-
tain submicroscopic hemozoin.11 During LDMS, hemozoin
crystals efficiently absorb UV photons from a laser pulse,
which liberates intact iron protoporphyrin IX (heme) mol-
ecules and heme ions from the deposited blood sample. Mo-
lecular-structure-specific fragmentation of heme during this
desorption process produces a characteristic spectral signa-
ture based on the masses and relative abundances of the mo-
lecular ion and fragment ions.12–14 Importantly, heme bound
to hemoglobin in uninfected RBCs under normal physiologic
conditions is not detected by LDMS. In saponin and acetic
acid purifications of in vitro cultured parasites, LDMS has
been shown to be highly sensitive with a detection limit of less
than a femtomole of hemozoin heme, specific, and semiquan-
titative for P. falciparum hemozoin.14 In an in vivo nonlethal
Plasmodium yoelii mouse malaria model, LDMS accurately
followed the time course of infection as monitored by thin
film optical microscopic examination and a colorimetric
hemozoin assay and did so with greater sensitivity in both
cases.12
This human study examined the efficacy of LDMS for de-
tecting P. falciparum malaria in a group of asymptomatic
pregnant Zambian women who presented for routine antena-
tal follow-up and presumptive treatment of malaria infection
with sulfadoxine-pyrimethamine. The LDMS results are com-
pared with optical microscopy and PCR analysis. Prior to the
initiation of this study, the efficiency of LDMS for detecting
early-stage P. falciparum–infected erythrocytes using our
simple blood dilution sample prepation protocol (vide infra)
was not known. For this reason, we did not know a priori the
blood volume that needed to be examined by LDMS for the
direct comparative analysis of sensitivity and specificity with
the other diagnostic methods. In this initial study, less than 1
L of whole blood per patient was scanned by LDMS for the
presence of hemozoin, while the sample preparation for PCR
analysis processed about 20–30 L of whole blood. Micros-
copy results were based on examination 100 thick-film fields
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of a Giemsa-stained blood smear, or roughly 0.1–0.25 L of
whole blood. LDMS of P. falciparum culture parasites diluted
in whole blood was also performed to help interpret the hu-
man subject data, to estimate detection efficiency for infected
erythrocytes, and also to guide the development of an assay
protocol suitable for future diagnostic use. This study was
conducted as part of a larger study, also reported here, aimed
at examining the frequency of drug-resistant genotypes as
predictors of parasite resistance to chloroquine or sulfadox-
ine-pyrimethamine in Zambia.
MATERIALS AND METHODS
Study site and subjects. The study to examine drug-
resistant molecular markers to sulfonamide and pyrimeth-
amine during pregnancy was conducted during March–June
2003 at the outpatient maternal-child health service in Macha
Mission Hospital, Choma district, southern Zambia. P. falci-
parum infection is the most common diagnosis and one of the
top 10 causes of child mortality and maternal morbidity in the
Macha area. The peak of malaria transmission, associated
with an entomological inoculation rate of 2–20 per week, oc-
curs during the rainy season from December to June. During
the other months, many residents have low-level parasitemias
without symptoms and are considered semi-immune to ma-
laria. About 20% of live births have a low birth weight and
25% of pregnancies result in stillbirths (Macha Hospital An-
nual Report, 2000).
Fifty-two women were recruited and screened from the
Macha antenatal clinic and also five mobile clinics surround-
ing the hospital. The nature and detailed procedures of the
study were described both verbally and in writing in Chi-
tonka, the native language. Exclusion criteria included
women whose gestational duration was less than 12 weeks,
whose age was less than 21 years, who had a history of allergy
to sulfa drugs or pyrimethamine, who were unavailable for a
follow-up, who lived outside of a radius of approximately 20
km, or who have participated in other drug studies in the past
90 days. After written consents were obtained from the
women eligible for the study, a complete history was taken,
physical and obstetric examinations were performed, finger-
prick blood collected, and sulfadoxine and pyrimethamine
was given. Thick blood smears were air-dried and stained
with Giemsa stain. The smears were read independently by
two microscopists. A third reader was available if there was a
disagreement between the two. Blood samples were also de-
posited onto filter papers for subsequent PCR analysis. Three
additional positive controls from children presenting to the
clinic for malaria were processed in a similar fashion. Finally,
25 negative nonendemic control patient samples were ob-
tained from unlinked, unidentifiable leftover blood collec-
tions from the hematology laboratory at Johns Hopkins Hos-
pital. The antenatal study and other blood collections were
approved by the local hospital management board, the Zam-
bian UNZA Research Ethics Committee, as well as the Com-
mittee on Human Research of the Johns Hopkins University
(JHU) Bloomberg School of Public Health.
Parasite culture. P. falciparum, strain 3D7, was maintained
in culture plates at 37°C and 5% parasitemia in RPMI 1640
supplemented with 10% (v/v) heat inactivated human serum
under a O2/CO2/N2 atmosphere as described by Trager and
Jensen.15 Cultures were synchronized by sorbitol lysis,16
washed in PBS to minimize extracellular hemozoin, and di-
luted into whole blood at 50% hematocrit to 100, 1,000,
10,000, and 100,000 infected erythrocytes per microliter.
Samples were prepared using the early ring forms and tro-
phozoite stage.
LDMS. For LDMS metal slide preparation, 2 L of human
whole blood was diluted with addition of 18 L of distilled
water. A 0.2-L aliquot of the mixture was pipetted onto each
of 20 wells of a metal slide, air-dried, and stored in a 15-mL
plastic conical tube at room temperature for up to a year. The
metal slides in the conical tubes were shipped by air to the
Johns Hopkins University. Only 45 patient samples out of 52
were available for LDMS analysis. Samples from P. falci-
parum culture were run in triplicate (3 slides, 20 wells each) at
each parasitemia. Each metal slide was inserted into a com-
mercial time-of-flight mass spectrometer (Kratos Discovery,
Shimadzu Analytical, Chesnut Ridge, NY). Positive ioniza-
tion laser desorption mass spectra were acquired in the linear
mode with a 20-kV delayed extraction potential as previously
described.12,14 The laser fluence (∼100 J/cm2) was optimized
for the sensitivity and specificity of detection of both the
heme molecular ion and heme-specific fragment ions. The
laser beam was rastered linearly across each sample well, 2
mm in length, in 20 m steps, and LDMS spectra were ac-
quired from each location. One hundred individual laser shot
spectra were acquired for each of 20 wells for a total of 2,000
spectra per patient sample. Previous investigation of this pro-
tocol using UV sensitive paper inserted into the mass spec-
trometer indicated that only ∼25% of the 0.2 L dried, diluted
blood in each well was interrogated by the laser beam (beam
width ∼100 m). Thus, for the 20 wells, the surface of ∼1 L
of the dried, diluted whole blood was interrogated for the
presence of parasite hemozoin, or ∼0.1 L of original whole
blood.
Mass spectral data processing. Individual spectra were ini-
tially processed by in-house written software in which a heme
spectral matching filter is applied.12,14 The filter compares
each individual spectrum to a template heme spectrum and
yields a score, h (0  h  1.0), representing the degree of
correlation between the observed spectrum and the template.
A low score h ∼0.0 corresponds to a poorly conforming spec-
trum, while high scores, h ∼1.0, indicate a highly conforming
spectrum. The template for this study was derived from an
average hemozoin spectrum from a P. yoelii–infected mouse.
For this study, spectra with h  0.45, and signal-to-noise
(SNR) ratio > 50 were designated as containing heme from
hemozoin (Feldman AB and others, in preparation). The
SNR value was computed by forming the ratio of the inte-
grated ion signal intensity within the template mass/charge
(m/z) range (450 to 616) to that in two m/z domains (each half
the width of the template range) adjacent to the low-end and
high-end of the template.
PCR analysis. Each filter paper (1 × 2 cm2) was air-dried
and stored in an individual sealed plastic bag at room tem-
perature for up to a year. Parasite DNA was extracted from
the filter paper by a modified standard saponin extraction
method.17 The strips were placed in 1 mL of 0.5% saponin in
phosphate-buffered saline (PBS), soaked for 15 minutes at
37°C, and incubated overnight at 4°C. The supernatant was
aspirated out and replaced with 1 mL of PBS. The tubes were
incubated at 4°C for 30 minutes. The PBS was aspirated out,
and 200 L of heated water treated with 20% chelex-100
NYUNT AND OTHERS486
(Bio-Rad, Richmond, CA). The tubes were vortexed at high
speed for 20 seconds, placed in a cycler at 95°C for 10 min-
utes, vortexed briefly once again, and centrifuged. After cen-
trifugation, the supernatant was collected and used for PCR
or stored at 4°C. A nested PCR reaction was performed by
established protocols and primers.18–20 Positive PCR tem-
plates were restricted to detect the multiple single nucleotide
polymorphisms for the genes for merozoite surface protein 2
(Pfmsp2), chloroquine-resistance (PfCRT), quinoline-
resistance modulation (PfMDR1), pyrimethamine-resistance
(PfDHFR), and sulfadoxine-resistance (PfDHPS).
RESULTS
Demographics. Fifty-two asymptomatic women with an av-
erage age of 26 years (range 21–39) were enrolled in the
study. Only 8% of women were primigravida or secunda-
gravida. Forty percent of women were in their second trimes-
ter and the rest were in their third trimester (average of 6.6
months gestation). None were microscopy positive for P. fal-
ciparum parasites upon presentation to the clinic. Twenty-
nine of 52 samples had a positive amplification product on
multiple nested PCR reactions.
LDMS. Seven metal slides from the group of 52 enrolled
patients, including 4 that were PCR positive, were not avail-
able for LDMS examination. LDMS spectra were analyzed
for the presence of hemozoin, and for each patient sample the
number of spectra with detected heme out of the 2,000 ac-
quired was recorded. Representative spectra from malaria-
infected and noninfected subjects are averaged over the 2,000
total laser shot spectra (Figure 1). The heme signal from P.
falciparum hemozoin is a cluster of peaks at m/z 616 for intact
iron protoporphyrin IX, and at m/z 571, 557, 527, 511, 498,
and 485 for the fragment ions derived from iron protopor-
phyrin IX. The spectrum from a Zambian, microscopy smear
positive, P. falciparum control had 27 spectra that were posi-
tive for heme according to our detection criteria (Figure 1A).
This spectrum is similar to a representative spectrum of a
pregnant patient’s blood that was microscopy negative, but
PCR positive (Figure 1B). This sample had only three posi-
tive spectra with detected heme (out of 2,000 overall spectra).
The LDMS spectrum from the negative control, a JHU pa-
tient, clearly has no characteristic pattern of heme ion peaks
(Figure 1C). In total, LDMS detected P. falciparum infection
in 15 patients, none of which were identified by microscopy
(Table 1). While we have used a signal processing algorithm
to determine the presence of hemozoin heme in each single
laser shot spectrum, heme is readily identifiable visually in
these individual spectra (Figure 2). Single-shot heme positive
spectra from two PCR positive and one PCR negative ante-
natal sample all had hemozoin template matching filter scores
h > 0.5. Both of the LDMS-positive/PCR-negative patient
samples had only one positive heme signal spectrum out of
the 2,000 as did 8 other LDMS positive samples that were also
PCR positive. Comparison of the LDMS test performance
versus PCR in a Fisher’s exact test for significantly different
proportions (Table 2) demonstrated a P value of 0.003, indi-
cating the concordance of the LDMS and PCR results was
unlikely to have occurred by chance. The sensitivity of the 0.1
L LDMS assay is 52% and specificity of 92%, compared
with the PCR standard.
An LDMS standard curve from laboratory culture of syn-
chronized P. falciparum early rings and P. falciparum tropho-
zoites was generated to compare the count of heme detections
to sample parasitemia and to estimate the detection efficiency
of infected erythrocytes (Figure 3). The error bars indicate 1
standard error of the mean based on the 3 replicate samples.
Results for the endemic positive controls are shown for com-
parison. The positive non-pregnant Zambian controls had 6,
27 and 37 positive heme signal spectra corresponding to
11,799, 27,830 and 109,911 parasites per microliter, respectively.
Drug-resistance genotyping. Each of the PCR positive
samples had different nested PCR-RFLP banding pattern for
the Pfmsp2 gene as expected in this region of Africa with high
parasite diversity. The chloroquine-resistant genotype PfCRT
K76T was present in all of the PCR positive samples with only
one mixed sensitive and resistant genotype. The Pfmdr1
N86Y was present in 88% of the samples with 28% mixed
sensitive and resistant genotype. The dihydrofolate reductase
S108N allele was present in all of the samples indicating Re-
sistance level 1 (Res1) to antifolate drugs (Figure 4).4 The
DHPS genotype resistance was present at less than 20% of
samples. Only one sample had all five DHFR-DHPS muta-
tions indicating high level drug resistance (Res2).4 All the
patients including the PCR positive patients were blood film
and PCR negative on follow-up visit, indicating full parasito-
logical response to antifolate medications.
DISCUSSION
Diagnosis of malaria during pregnancy in women who live
in endemic areas is complicated by sequestration of parasites
FIGURE 1. LDMS spectra: A, a positive endemic control, 27 indi-
vidual shot spectra averaged; B, a microscopy negative, but PCR
positive blood sample, 3 individual shot spectra averaged. C, The
LDMS spectrum of a nonendemic negative control blood sample has
background ions but clearly contains no heme. Heme characteristic
ion peaks at mass/charge values of 616, 571, 557, 527, 511, 498, and
485 are indicated by the arrows. Background ions, unrelated to heme,
are indicated by an asterisk.
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in the placenta, which reduces the number of circulating ring-
stage parasites in peripheral blood able to be identified by
traditional Giemsa stain–based microscopy. All patients in
this study were enrolled during the peak malaria season and
were blood film negative, but some were PCR positive and
LDMS positive, suggesting low ring-stage parasitemias in
these patients. Ginsburg and others have measured the hemo-
zoin content of ring-, trophozoite-, and schizont-stage para-
sites to be approximately 1, 3, and 4–5 micromoles per 1010
parasites, respectively. These correspond to an average of 0.1,
0.3, 0.4–0.5 femtomoles per parasite, which suggests that
LDMS, with subfemtomole sensitivity for heme, can detect
hemozoin from a single individual infected erythrocyte. Even
though hemozoin is not visible under light microscopy in ring-
stage parasites, electron micrographs depict recognizable
heme crystals during this stage.11 The LDMS detection of
heme in clinical P. falciparum samples is further evidence of the
presence of submicroscopic hemozoin in ring-stage parasites.
The general agreement between the heme detection counts
for the endemic positive controls and those predicted by the
ring-stage standard curve suggests that the population of ring-
stage parasites harvested from the culture is reasonably rep-
resentative of an in vivo population. Note also that the de-
tection count tracks the parasitemia in the range of clinical
interest from 0.1% parasitemia. The number of heme detec-
tions per 2,000 laser pulses is quite low, indicating a low ef-
ficiency of detection of infected erythrocytes. For example, at
10,000 parasites per microliter, the LDMS assay scanned the
surface of a dried blood volume containing ∼1000 ring-stage
parasites and averaged ∼10 heme positive spectra (∼1% effi-
ciency). This value is actually an upper bound to the true
efficiency, as detections sometimes occurred in spatially con-
tiguous clusters (consecutive pulses), which is expected when
the beam width is much larger than the beam step used during
sample scanning. “Shading” effects, that is, overlapping of
TABLE 2





Positive 13 2 15
Negative 12 18 30
Total 25 20 45
PCR analyzed 20–30 L of blood, whereas LDMS analyzed approximately a tenth of a
microliter of whole blood. Sensitivity is 52%, specificity is 92%, and P value is 0.003.
TABLE 1
Comparison of parasitemia, PCR result, and number of LDMS heme
shot detections out of 2,000 laser shots for human samples and








E005 neg pos 1
E006 neg pos 1
E007 neg pos 1
E017 neg pos 1
E027 neg pos 1
E028 neg pos 1
E032 neg neg 1
E040 neg pos 1
E049 neg neg 1
E009 neg pos 2
E019 neg pos 2
E035 neg pos 2
E016 neg pos 3
E044 neg pos 3
E031 neg pos 4
Children ma03081 11,799 pos 6
positive ma04083 27,830 pos 27





Trophozoites 100 N.D. 0
Trophozoites 100 N.D. 5
Trophozoites 100 N.D. 6
Trophozoites 1,000 N.D. 13
Trophozoites 1,000 N.D. 19
Trophozoites 1,000 N.D. 21
Trophozoites 10,000 N.D. 88
Trophozoites 10,000 N.D. 142
Trophozoites 10,000 N.D. 157
Trophozoites 100,000 N.D. 50
Trophozoites 100,000 N.D. 111
Trophozoites 100,000 N.D. 151
Rings 1,000 N.D. 0
Rings 1,000 N.D. 2
Rings 1,000 N.D. 3
Rings 10,000 N.D. 11
Rings 10,000 N.D. 12
Rings 10,000 N.D. 15
Rings 100,000 N.D. 35
Rings 100,000 N.D. 59
Rings 100,000 N.D. 60
N.D., not determined.
FIGURE 2. Single-shot LDMS spectra with detected heme from
two PCR positive (A, B) and a PCR negative (C) patient. A value of
h  0.45 was required for an individual laser shot spectrum to be
classified as a heme detection.
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infected with uninfected erythrocytes when samples are pre-
pared following the dilution protocol used here, likely con-
tributes to the low detection efficiency we observed.
Another important feature of the in vitro data is that the
number of heme detections is an order of magnitude higher
for trophozoites than for ring-stage at comparable parasit-
emias. This indicates that the more mature parasite forms are
detected more efficiently by the LDMS method, presumably
due to the larger and more numerous hemozoin crystals. It
also suggests that for a fixed blood volume analyzed, LDMS
will on average be more sensitive for the three non-
falciparum species of human Plasmodium, in which the later
stage parasites circulate in the peripheral blood. This is not
normally the case for P. falciparum, where later stage para-
sites sequester in internal organs. Previous pilot studies dem-
onstrated detection of Plasmodium vivax infection at parasit-
emias < 100 parasites per microliter using the identical sample
preparation protocol as in this study.21 The data in Figure 2
and Table 1 show the detection of P. falciparum trophozoites
at 100 parasites per l, but in only 2 out of the 3 replicates
tested. A similar detection probability was found for P. falci-
parum rings at 1,000 parasites per microliter. Generally, the
probability of detecting infection by LDMS depends on the
parasite stages, the detection efficiency for each stage, and the
total blood volume scanned by the laser. When the expected
detection count is low (e.g., extrapolating Figure 3 suggests
that for ring stages, only 0.2 detections are expected per 2000
spectra at 100 parasites per microliter), it is possible to in-
crease the detection probability by increasing the blood vol-
ume analyzed. The detection counts will scale linearly with
the amount of blood scanned. As the limit of detection for
field microscopy is ∼100–1,000 per microliter, the LDMS de-
tection of 13 microscopy negative, malaria positive cases out
of 25 positive PCR cases is evidence that the trial LDMS
assay performed here was sensitive for P. falciparum parasit-
emias in the 100–1,000 per microliter range, but the probabil-
ity of detection was only modest in this range. For the LDMS
positive samples, four patients had 3 or more heme detec-
tions, three patients had 2 heme detections, and nine patients
had only 1 heme detection per 2,000 spectra. Based on the
ring-stage standard curve, we can infer that the parasitemias
for the pregnant patients were in the 200–1,000 parasites per
microliter range. A more quantitative analysis of the in vitro
data based on Poisson counting statistics (Feldman AB and
others, in preparation) predicts an average detection prob-
ability for this 0.1 L–based LDMS assay to be ∼50% over the
10–1,000 parasites per microliter parasitemia range. This is in
good agreement with our clinical finding of 52% (13 LDMS
positive out of 25 PCR-positive), assuming the parasitemias
of these samples are distributed uniformly over this parasit-
emia range.
FIGURE 3. Comparison of parasitemia versus number of LDMS
heme signal detections for in vitro cultured synchronized P. falci-
parum parasites. Trophozoites (circles), which by definition contain
more hemozoin, scored a higher number of heme detection counts
than rings (triangles) for a given parasite dilution. The three blood
samples from P. falciparum smear positive patients are also indicated
(empty squares). Values are means of triplicate measurements.
FIGURE 4. Fraction of DHFR and DHPS drug-resistant mutations
out of 25 PCR positive patients.
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The two samples that were LDMS positive and PCR nega-
tive could have resulted from detection of leukocytes contain-
ing hemozoin, but not parasite DNA. When the ruptured
infected erythrocyte releases merozoites, the residual body
containing remnant parasite membranes surrounding hemo-
zoin is released into the circulation. Hemozoin and/or the
residual body containing hemozoin can be ingested by circu-
lating neutrophils or monocytes. Immunochromatographic
tests can detect sequestered parasites in pregnant patients
through circulating antigens, as the schizont rupture of the
infected erythrocytes in placental tissues releases P. falci-
parum aldolase, HRP II, or lactate dehydrogenase into the
plasma in addition to that contained inside circulating eryth-
rocytes. Therefore, like the immunochromatagraphic tests,
LDMS has the capability to detect the molecular remnants of
previous generations of P. falciparum parasites, in addition to
the intact intraerythrocytic ring-stage parasites in the blood
sample.
This work establishes the detection of the predominant
ring-infected erythrocytes of P. falciparum by LDMS. The
field and hospital use of LDMS will require further study in
larger clinical trials using more carefully designed assay pro-
tocols that scan sufficient blood to meet a targeted sensitivity
and probability of detection. A potential role may be as a
screening tool of large populations before more time- and
labor-intensive diagnostics are used. The current develop-
ment of miniature, field-portable MS systems may make this
LDMS method more widely available. Although the LDMS
instrument costs are expensive, the protocol we have devel-
oped is simple-to-perform, rapid, and requires no consum-
ables other than water and a lancet for obtaining the droplet
of blood.
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